CEO & Board Chair @ ENDRA Life Sciences (Nasdaq: NDRA) • MedTech Innovation • IPO • Transforming Early Detection of Liver Disease
ENDRA's TAEUS technology on display at EASD in Hamburg. The excellent traffic we're seeing is a testament to the growing interest in liver health as a metabolic biomarker in endocrinology. #ENDRA #TAEUS #EASD #SLD #MAFLD #liverhealth #endocrinology